Erectile dysfunction in patients with spina bifida is a treatable condition

被引:60
作者
Palmer, JS [1 ]
Kaplan, WE [1 ]
Firlit, CF [1 ]
机构
[1] Northwestern Univ, Sch Med, Childrens Mem Hosp, Div Urol, Chicago, IL 60611 USA
关键词
spinal dysraphism; meningomyelocele; impotence;
D O I
10.1016/S0022-5347(05)67225-4
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: Now that individuals with spina bifida live well into adulthood erectile dysfunction has become a recognized associated medical disorder. To our knowledge no study has dealt specifically with treatment of erectile dysfunction in men with spina bifida. Therefore, we conducted a prospective, blinded, randomized, placebo controlled, dose escalation, crossover study to determine the ability to treat erectile dysfunction in men with spina bifida with sildenafil citrate. Materials and Methods: Erectile dysfunction was diagnosed in 15 men 19 to 35 years old with spina bifida who were assigned to take 4 sets of tablets, 5 tablets per set, in a random order. All patients took 25 and 50 rug. sildenafil and 2 identical looking sets of corresponding placebos I hour before planned sexual activity. Efficacy was assessed by the effect of treatment compared to baseline, that is before treatment, on rating of erections (scored from 0 to 10), duration of erections, frequency of erections based on response to question 1 (scored from 0 to 5) of the International Index of Erectile Function and confidence to obtain an erection based on response to question 15 (scored from 1 to 5) of the International Index of Erectile Function. Results: Improved erectile function was reported while on sildenafil by 12 (80%) men compared to baseline and placebos. There was a significant dose dependent improvement of erectile function with both 25 and 50 mg. sildenafil compared to baseline (p < 0.05), as mean erectile score increased by 50% and 88%, mean duration of erections increased by 192% and 266%, mean frequency of erections increased by 61% and 96%, and mean level of confidence increased by 33% and 63%, respectively. Furthermore, 50 mg. sildenafil provided greater improvement in all 4 parameters compared to 25 mg. The placebo results were not significantly different compared to baseline for any of the parameters. Conclusions: Erectile dysfunction in patients with spina bifida is a medically treatable condition. Sildenafil is effective in this patient population and improves level of sexual confidence.
引用
收藏
页码:958 / 961
页数:4
相关论文
共 7 条
[1]  
DROLLER MJ, 1993, JAMA-J AM MED ASSOC, V270, P83
[2]   Oral sildenafil in the treatment of erectile dysfunction [J].
Goldstein, I ;
Lue, TF ;
Padma-Nathan, H ;
Rosen, RC ;
Steers, WD ;
Wicker, PA .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (20) :1397-1404
[3]   Sexuality and reproductive issues in children with myelomeningocele [J].
Joyner, BD ;
McLorie, GA ;
Khoury, AE .
EUROPEAN JOURNAL OF PEDIATRIC SURGERY, 1998, 8 (01) :29-34
[4]  
LUE TF, 1998, CAMPBELLS UROLOGY, P1181
[5]   Erectile dysfunction in spina bifida is treatable [J].
Palmer, JS ;
Kaplan, WE ;
Firlit, CF .
LANCET, 1999, 354 (9173) :125-126
[6]   The international index of erectile function (IIEF): A multidimensional scale for assessment of erectile dysfunction [J].
Rosen, RC ;
Riley, A ;
Wagner, G ;
Osterloh, IH ;
Kirkpatrick, J ;
Mishra, A .
UROLOGY, 1997, 49 (06) :822-830
[7]   THE CHANGING EPIDEMIOLOGY OF NEURAL-TUBE DEFECTS - UNITED-STATES, 1968-1989 [J].
YEN, IH ;
KHOURY, MJ ;
ERICKSON, JD ;
JAMES, LM ;
WATERS, GD ;
BERRY, RJ .
AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1992, 146 (07) :857-861